Companydirectory

• Funding £1,095,180
• Competition Cancer
• Competition Date Autumn 2013
• Local AHSN East Midlands AHSN
• Status Clinical Trials

• Cancer
• In-vitro Diagnostics

For high throughput fluid-flow cell imaging for bladder cancer monitoring and diagnosis, Astrimmune has developed the unique capability to biochemically analyse and image individual cells en masse ...

• Funding £100,000
• Competition Medical Imaging
• Competition Date Autumn 2014
• Local AHSN East Midlands AHSN
• Status Clinical Trials

• Cancer
• In-vitro Diagnostics

Biovici is developing a proof of concept sensor capable of detecting a drug and or relevant biomarkers. The biosensor uses nanotechnology to provide rapid point of care, non-invasive diagnostic mo...

• Funding £98,828
• Competition Medicines Adherence
• Competition Date Spring 2014
• Local AHSN West of England AHSN
• Status In Development

• Medicines Adherence
• In-vitro Diagnostics

Biovici proposes to develop an affordable, portable, point of care test to detect the presence of biomarkers linked with Traumatic Brain Injury (TBI). The device will identify biomarkers present in...

• Funding £95,303
• Competition Reducing Pressure on Urgent & Emergency Care
• Competition Date Autumn 2015
• Local AHSN West of England AHSN
• Status Proof of Concept

• Brain Injury
• In-vitro Diagnostics

• Funding £1,099,284
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN Eastern AHSN
• Status Proof of Concept

• Cancer
• In-vitro Diagnostics

• Funding £1,099,939
• Competition GP of the Future - Self Care
• Competition Date Autumn 2016
• Local AHSN Eastern AHSN
• Status Proof of Concept

• Respiratory
• In-vitro Diagnostics

700,000 people experience heart attack symptoms annually, and will experience the agony of a long wait for test results. Capillary Film Technology (CFT) has developed affordable microfluidic testin...

• Funding £1,096,610
• Competition Research Tools
• Competition Date Autumn 2013
• Local AHSN Kent Surrey Sussex AHSN
• Status Clinical Trials

• Cardiovascular
• In-vitro Diagnostics

• Funding £98,740
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN North East & North Cumbria AHSN
• Status Proof of Concept

• Cancer
• In-vitro Diagnostics

Particularly In the elderly, urinary tract infection is a common problem, it s often associated with catheter use. It can become very severe, with rapid onset of confusion and can be very disturbin...

• Funding £1,080,723
• Competition Reducing Pressure on Urgent & Emergency Care
• Competition Date Autumn 2015
• Local AHSN Greater Manchester AHSN
• Status Proof of Concept

• In-vitro Diagnostics

COPD is the second most common cause of emergency admissions in the UK, responsible for one in eight acute adult medical admissions. Mologic is developing a urine based test for an early indication...

• Funding £100,000
• Competition Reducing Pressure on Urgent & Emergency Care
• Competition Date Autumn 2015
• Local AHSN Eastern AHSN
• Status Proof of Concept

• In-vitro Diagnostics